Target intelligence / Profile preview

Hard masses

01

Overview

"Hard masses" is a clinical descriptor used to characterize firm, palpable, and localized swellings or growths identified during a physical examination or via diagnostic imaging; it does not represent a specific molecular target, protein, or receptor (National Cancer Institute, 2024). These structures are macroscopic manifestations of various underlying pathological conditions, including malignant tumors, benign neoplasms, cysts, or localized areas of chronic inflammation and fibrosis (StatPearls, 2023). Because the term refers to a physical characteristic of tissue rather than a specific biochemical entity, it lacks a defined molecular classification, intrinsic biological signaling function, or direct interacting drugs. Therapeutic interventions are not designed to target the "hardness" of a mass itself but are instead directed at the specific cellular drivers or pathogens identified within the mass following a biopsy or histological analysis. Consequently, "Hard masses" is categorized as an incorrect entry for a pharmacological target database as it lacks a singular molecular identity.

Other names
Solid massPalpable lesionIndurated massTumorNeoplasm
02

Disease associations

CancerBenign neoplasmFibrosisInfectionCalcification
03

Safety considerations

Diagnostic ambiguityRisk of underlying malignancyBiopsy-related complications
04

Biomarkers

Physical examinationRadiographic imaging (CT/MRI/Ultrasound)Histopathology via biopsy

Beyond the preview

Go deeper on Hard masses.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hard masses.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call